Renagel (Aphena Pharma Solutions – Tennessee, LLC)
Welcome to the PulseAid listing for the Renagel drug offered from Aphena Pharma Solutions – Tennessee, LLC. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Aphena Pharma Solutions – Tennessee, LLC |
NON-PROPRIETARY NAME: | Renagel |
SUBSTANCE NAME: | SEVELAMER HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2008-06-06 |
END MARKETING DATE: | 0000-00-00 |
Renagel HUMAN PRESCRIPTION DRUG Details:
Item Description | Renagel from Aphena Pharma Solutions – Tennessee, LLC |
LABELER NAME: | Aphena Pharma Solutions – Tennessee, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 800(mg/1) |
START MARKETING DATE: | 2008-06-06 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67544-656_7bba784e-b2dd-4662-a66d-09246be23c7c |
PRODUCT NDC: | 67544-656 |
APPLICATION NUMBER: | NDA021179 |
Other SEVELAMER HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: